NAD+
The central redox coenzyme — supplied at 100, 500 and 1000 mg per vial.
Available sizes
| SKU | Per vial | Pack | |
|---|---|---|---|
| NJ100 | 100 mg | 10 vials / box | |
| NJ500 | 500 mg | 10 vials / box | |
| NJ1000 | 1000 mg | 10 vials / box |
Order NAD+
Pricing is quoted directly and is competitive at every tier — message us with the SKUs you want and quantities for a quote.
Replies within 36 hours. Cryptocurrency (preferred) or card / money-app with a processing fee. COA for this batch available on request.
Nicotinamide adenine dinucleotide (NAD+) is the essential coenzyme for cellular redox reactions and the substrate for sirtuins, PARPs and CD38. Tissue NAD+ levels decline with age, and restoring them is a major focus of longevity research.
A Cell Metabolism review of the in-vivo evidence summarises how NAD+ repletion improves mitochondrial function, metabolic health and healthspan markers across numerous animal models, and outlines the state of human trials 1.
At a glance
- Essential redox coenzyme; sirtuin/PARP substrate
- Extensive preclinical longevity literature
- 100 mg, 500 mg and 1000 mg vials
- Form
- Lyophilized powder
- Purity
- HPLC-verified — Certificate of Analysis available on request
- Pack size
- Box of 10 vials
- Storage
- Lyophilized: −20 °C, protected from light (2–8 °C short-term). Reconstituted: 2–8 °C.
- Formula
- C21H27N7O14P2
- Mol. weight
- 663.4 g/mol
- CAS No.
- 53-84-9
Sequence, formula and CAS data are provided for identification. Batch-specific purity, mass-spec and HPLC data are on the Certificate of Analysis — ask for it with your order.
- Rajman L, Chwalek K, Sinclair DA Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell Metab. 2018;27(3):529-547.
Citations retrieved from PubMed (NCBI). Links open the publisher record via DOI and the PubMed abstract.
Often ordered together
5-Amino-1MQ
Small-molecule NNMT inhibitor studied in adipocyte and diet-induced obesity models.
Glutathione
The primary intracellular antioxidant tripeptide — 1.5 g per vial.